Annual Cash & Cash Equivalents
$20.15 M
+$1.34 M+7.13%
March 31, 2024
Summary
- As of February 26, 2025, CJJD annual cash & cash equivalents is $20.15 million, with the most recent change of +$1.34 million (+7.13%) on March 31, 2024.
- During the last 3 years, CJJD annual cash & cash equivalents has fallen by -$1.90 million (-8.60%).
- CJJD annual cash & cash equivalents is now -8.60% below its all-time high of $22.05 million, reached on March 31, 2021.
Performance
CJJD Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$18.00 M
-$2.15 M-10.66%
September 30, 2024
Summary
- As of February 26, 2025, CJJD quarterly cash and cash equivalents is $18.00 million, with the most recent change of -$2.15 million (-10.66%) on September 30, 2024.
- Over the past year, CJJD quarterly cash and cash equivalents has stayed the same.
- CJJD quarterly cash and cash equivalents is now -26.86% below its all-time high of $24.61 million, reached on September 30, 2021.
Performance
CJJD Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CJJD Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.1% | 0.0% |
| 3 y3 years | -8.6% | 0.0% |
| 5 y5 years | +116.1% | -16.8% |
CJJD Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.6% | +9.2% | -26.9% | +27.3% |
| 5 y | 5-year | -8.6% | +116.1% | -26.9% | +51.8% |
| alltime | all time | -8.6% | >+9999.0% | -26.9% | >+9999.0% |
China Jo-Jo Drugstores Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.00 M(-10.7%) |
| Mar 2024 | $20.15 M(+7.1%) | $20.15 M(+8.0%) |
| Sep 2023 | - | $18.65 M(-0.8%) |
| Mar 2023 | $18.81 M(+1.9%) | $18.81 M(+33.0%) |
| Sep 2022 | - | $14.14 M(-23.4%) |
| Mar 2022 | $18.46 M(-16.3%) | $18.46 M(-25.0%) |
| Sep 2021 | - | $24.61 M(+11.6%) |
| Mar 2021 | $22.05 M(+36.3%) | $22.05 M(+81.9%) |
| Dec 2020 | - | $12.12 M(-44.0%) |
| Sep 2020 | - | $21.65 M(+17.2%) |
| Jun 2020 | - | $18.48 M(+14.2%) |
| Mar 2020 | $16.18 M(+73.5%) | $16.18 M(+36.4%) |
| Dec 2019 | - | $11.86 M(-31.8%) |
| Sep 2019 | - | $17.40 M(+108.5%) |
| Jun 2019 | - | $8.34 M(-10.5%) |
| Mar 2019 | $9.32 M(-38.4%) | $9.32 M(+65.9%) |
| Dec 2018 | - | $5.62 M(-18.8%) |
| Sep 2018 | - | $6.92 M(-22.3%) |
| Jun 2018 | - | $8.91 M(-41.2%) |
| Mar 2018 | $15.13 M(-17.6%) | $15.13 M(+80.2%) |
| Dec 2017 | - | $8.40 M(-50.1%) |
| Sep 2017 | - | $16.84 M(+17.3%) |
| Jun 2017 | - | $14.36 M(-21.8%) |
| Mar 2017 | $18.36 M(+175.2%) | $18.36 M(+295.5%) |
| Dec 2016 | - | $4.64 M(-44.4%) |
| Sep 2016 | - | $8.35 M(+65.1%) |
| Jun 2016 | - | $5.06 M(-24.2%) |
| Mar 2016 | $6.67 M(+65.8%) | $6.67 M(+53.8%) |
| Dec 2015 | - | $4.34 M(-35.3%) |
| Sep 2015 | - | $6.71 M(+305.5%) |
| Jun 2015 | - | $1.65 M(-58.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | $4.02 M(-9.5%) | $4.02 M(+132.0%) |
| Dec 2014 | - | $1.73 M(-76.4%) |
| Sep 2014 | - | $7.35 M(+117.6%) |
| Jun 2014 | - | $3.38 M(-24.0%) |
| Mar 2014 | $4.45 M(-1.7%) | $4.45 M(+43.1%) |
| Dec 2013 | - | $3.11 M(-50.7%) |
| Sep 2013 | - | $6.30 M(+132.2%) |
| Jun 2013 | - | $2.71 M(-40.1%) |
| Mar 2013 | $4.52 M(+18.0%) | $4.52 M(+19.2%) |
| Dec 2012 | - | $3.80 M(+8.2%) |
| Sep 2012 | - | $3.51 M(-3.1%) |
| Jun 2012 | - | $3.62 M(-5.5%) |
| Mar 2012 | $3.83 M(-40.9%) | $3.83 M(-11.7%) |
| Dec 2011 | - | $4.34 M(-5.5%) |
| Sep 2011 | - | $4.59 M(-28.8%) |
| Jun 2011 | - | $6.45 M(-0.6%) |
| Mar 2011 | $6.49 M(+709.6%) | $6.49 M(-5.3%) |
| Dec 2010 | - | $6.85 M(-49.4%) |
| Sep 2010 | - | $13.54 M(-14.1%) |
| Jun 2010 | - | $15.77 M(+1867.9%) |
| Mar 2010 | $801.60 K(>+9900.0%) | $801.60 K(-34.7%) |
| Dec 2009 | - | $1.23 M(+49.7%) |
| Sep 2009 | - | $819.80 K(>+9900.0%) |
| Jul 2009 | $700.00(-56.3%) | $700.00(+250.0%) |
| Apr 2009 | - | $200.00(0.0%) |
| Jan 2009 | - | $200.00(-60.0%) |
| Oct 2008 | - | $500.00(-68.8%) |
| Jul 2008 | $1600.00(-94.7%) | $1600.00(-71.4%) |
| Apr 2008 | - | $5600.00(-75.0%) |
| Jan 2008 | - | $22.40 K(-24.1%) |
| Oct 2007 | - | $29.50 K |
| Jul 2007 | $30.40 K | - |
FAQ
- What is China Jo-Jo Drugstores annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for China Jo-Jo Drugstores?
- What is China Jo-Jo Drugstores annual cash & cash equivalents year-on-year change?
- What is China Jo-Jo Drugstores quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for China Jo-Jo Drugstores?
- What is China Jo-Jo Drugstores quarterly cash and cash equivalents year-on-year change?
What is China Jo-Jo Drugstores annual cash & cash equivalents?
The current annual cash & cash equivalents of CJJD is $20.15 M
What is the all time high annual cash & cash equivalents for China Jo-Jo Drugstores?
China Jo-Jo Drugstores all-time high annual cash & cash equivalents is $22.05 M
What is China Jo-Jo Drugstores annual cash & cash equivalents year-on-year change?
Over the past year, CJJD annual cash & cash equivalents has changed by +$1.34 M (+7.13%)
What is China Jo-Jo Drugstores quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CJJD is $18.00 M
What is the all time high quarterly cash and cash equivalents for China Jo-Jo Drugstores?
China Jo-Jo Drugstores all-time high quarterly cash and cash equivalents is $24.61 M
What is China Jo-Jo Drugstores quarterly cash and cash equivalents year-on-year change?
Over the past year, CJJD quarterly cash and cash equivalents has changed by $0.00 (0.00%)